WHO ICTRP trial
Observational cohort trial of immune response in patients with chronic health…
ISRCTN12821688 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN12821688 |
|---|---|
| Public title | Observational cohort trial of immune response in patients with chronic health conditions following coronavirus vaccination |
| Scientific title | Observational Cohort Trial-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2 |
| Primary sponsor | University of Birmingham |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Phase I |
| Countries | United Kingdom;England;Scotland |
| Conditions | Adult groups (18 years or above): patients with end-stage kidney disease, liver disease or gastrointestinal disease on immune suppressive therapy, cancer, immune-mediated rheumatic diseases (e.g. rheumatoid arthritis) and stem cell… |
| Interventions | Current interventions as of 08/08/2022: Three different groups of research samples are being assessed during the trial: Deep Immunophenotyping Group - each disease cohort will include 150 participants; blood and saliva samples are being… |
| Registration date | Feb 17, 2021 |
| Target size | 5160 |
| Secondary IDs | 2021-000569-33;Nil known;MX1034, sponsor number RG_21-007, IRAS 294480 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: